2:26-cv-04948 PHARMACOSMOS HOLDING A/S et al v. SANDOZ INC.
Corporate Disclosure Statement (aty) ( 4
Pharmacosmos Holding A/S and other plaintiffs filed a Corporate Disclosure Statement in the case against Sandoz Inc. This statement is a required filing that discloses the corporate structure and ownership of the plaintiffs. The statement is part of the ongoing litigation.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
2:26-cv-04948 PHARMACOSMOS HOLDING A/S et al v. SANDOZ INC.
Other · May 02, 2026
Coverage
1 article
1 source tracked
Participants
1 Plaintiff
2 linked entities
Judge
Not assigned in feed
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated May 02, 2026.
The visible party/entity graph currently includes 2:26-cv-04948 PHARMACOSMOS HOLDING A/S and others.
Press monitoring has found 1 related article from 1 distinct source.
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Pharmacosmos Holding A/S and other plaintiffs filed a Corporate Disclosure Statement in the case against Sandoz Inc. This statement is a required filing that discloses the corporate structure and ownership of the plaintiffs. The statement is part of the ongoing litigation.
Corporate Disclosure Statement (aty) ( 4
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
1 day, 5 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.